Discontinuation report MYLAN-GLICLAZIDE

Last updated on 2017-12-02 History
Report ID 16126
Drug Identification Number 02229519
Brand name MYLAN-GLICLAZIDE
Common or Proper name GLICLAZIDE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) GLICLAZIDE
Strength(s) 80MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100BT, 60BL
ATC code A10BB
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2017-12-01
Actual discontinuation date 2017-12-01
Remaining supply date 2017-12-01
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2017-12-02 English Compare
v6 2017-12-01 French Compare
v5 2017-12-01 English Compare
v4 2017-10-23 French Compare
v3 2017-10-23 English Compare
v2 2017-07-18 French Compare
v1 2017-07-18 English Compare

Showing 1 to 7 of 7